Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) closed at $31.60 in the last session, up 70.81% from day before closing price of $18.50. In other words, the price has increased by $70.81 from its previous closing price. On the day, 2.89 million shares were traded. RGC stock price reached its highest trading level at $31.64 during the session, while it also had its lowest trading level at $20.06.
Ratios:
We take a closer look at RGC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 41.92 and its Current Ratio is at 41.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGC now has a Market Capitalization of 411207648 and an Enterprise Value of 403331072.
Stock Price History:
The Beta on a monthly basis for RGC is -2.19, which has changed by 6.9197993 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, RGC has reached a high of $32.44, while it has fallen to a 52-week low of $3.03. The 50-Day Moving Average of the stock is 472.37%, while the 200-Day Moving Average is calculated to be 427.15%.
Shares Statistics:
According to the various share statistics, RGC traded on average about 551.13K shares per day over the past 3-months and 3449890 shares per day over the past 10 days. A total of 13.01M shares are outstanding, with a floating share count of 0.80M. Insiders hold about 93.84% of the company’s shares, while institutions hold 0.24% stake in the company. Shares short for RGC as of 1740700800 were 3918 with a Short Ratio of 0.01, compared to 1738281600 on 21712. Therefore, it implies a Short% of Shares Outstanding of 3918 and a Short% of Float of 0.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
